Skip to main content
Fig. 6 | Cell & Bioscience

Fig. 6

From: Nanotechnological engineering of extracellular vesicles for the development of actively targeted hybrid nanodevices

Fig. 6

Viability of lymphocytes (white bars) and Daudi (blue bars) 24 h after the SW treatment (i.e. 48 h after the nanoconstruct treatment). Cells were treated with SW alone, TNH, TNH in combination with SW (TNH_SW), TNHCD20, and TNHCD20 in combination with SW (TNHCD20_SW). Each column is normalized with respect the untreated cells and the experiments were conducted with n = 4. Statistical analysis: three-way ANOVA. **p ≤ 0.001, *p ≤ 0.05. The p value obtained for TNHCD20_SW between B lymphocytes and Daudi cells is p = 0.014

Back to article page